Average Co-Inventor Count = 7.13
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Research Technology Limited (10 from 263 patents)
2. Glaxosmithkline Intellectual Property Development Limited (1 from 230 patents)
10 patents:
1. 12129236 - PARG inhibitory compounds
2. 11680068 - Compounds useful as RET inhibitors
3. 11661423 - Heterocyclic compounds as RET kinase inhibitors
4. 11548896 - Heterocyclic compounds as RET kinase inhibitors
5. 11352361 - Compounds useful as RET inhibitors
6. 10975056 - Substituted pyridines as inhibitors of DNMT1
7. 10954241 - Heterocyclic compounds as ret kinase inhibitors
8. 10844067 - Heterocyclic compounds as RET kinase inhibitors
9. 10508086 - PARG inhibitory compounds
10. 10239843 - 2,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG